| |
| |
|
| Insider
Information: |
Elicker John E |
| Relationship: |
EVP, Investor Relations |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
70,946 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,855,577 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
70,946 |
|
|
| Total
Value |
$2,855,577 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 0.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Bristol-Myers Squibb Co |
BMY |
EVP, Investor Relations |
2020-03-10 |
70,946 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BMY |
Bristol-Myers Squibb Co |
SVP Pub Affairs & Inv Relation |
• • – |
2012-10-26 |
4 |
S |
$33.55 |
$74,280 |
D/D |
(2,214) |
22,697 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP Pub Affairs & Inv Relation |
• • – |
2013-02-11 |
4 |
S |
$36.97 |
$564,359 |
D/D |
(15,264) |
24,308 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP Pub Affairs & Inv Relation |
• • – |
2013-03-13 |
4 |
S |
$38.51 |
$131,281 |
D/D |
(3,409) |
33,727 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP Pub Affairs & Inv Relation |
• • – |
2013-06-05 |
4 |
S |
$46.33 |
$1,204,441 |
D/D |
(25,997) |
42,274 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP Pub Affairs & Inv Relation |
• – – |
2014-02-19 |
4 |
S |
$54.21 |
$516,911 |
D/D |
(9,534) |
32,740 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP Pub Affairs & Inv Relation |
• – – |
2015-03-06 |
4 |
S |
$66.24 |
$693,452 |
D/D |
(10,468) |
49,031 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Public Affairs & IR |
• – – |
2016-06-14 |
4 |
S |
$72.69 |
$859,219 |
D/D |
(11,820) |
55,011 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Public Affairs & IR |
• – – |
2019-11-05 |
4 |
S |
$56.66 |
$849,900 |
D/D |
(15,000) |
74,471 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, Investor Relations |
• – – |
2020-03-04 |
4 |
S |
$61.01 |
$964,263 |
D/D |
(15,805) |
58,666 |
0 |
% |
|
| BMY |
Bristol-Myers Squibb Co |
SVP Pub Affairs & Inv Relation |
• • – |
2013-02-11 |
4 |
OE |
$28.11 |
$474,356 |
D/D |
16,875 |
39,572 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP Pub Affairs & Inv Relation |
• • – |
2013-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,851 |
26,159 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP Pub Affairs & Inv Relation |
• • – |
2013-03-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,169 |
40,764 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP Pub Affairs & Inv Relation |
• • – |
2013-05-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,508 |
35,235 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP Pub Affairs & Inv Relation |
• • – |
2013-06-05 |
4 |
OE |
$17.51 |
$687,348 |
D/D |
33,715 |
68,271 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP Pub Affairs & Inv Relation |
• – – |
2014-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
17,471 |
51,061 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP Pub Affairs & Inv Relation |
• – – |
2014-03-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,043 |
47,630 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP Pub Affairs & Inv Relation |
• – – |
2014-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,850 |
49,399 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP Pub Affairs & Inv Relation |
• – – |
2014-05-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,509 |
50,536 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP Pub Affairs & Inv Relation |
• – – |
2015-01-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
952 |
50,808 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP Pub Affairs & Inv Relation |
• – – |
2015-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,360 |
51,827 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP Pub Affairs & Inv Relation |
• – – |
2015-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,250 |
60,609 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP Pub Affairs & Inv Relation |
• – – |
2015-03-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,043 |
59,141 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP Pub Affairs & Inv Relation |
• – – |
2015-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,271 |
52,348 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP Pub Affairs & Inv Relation |
• – – |
2015-11-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
496 |
52,286 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP Pub Affairs & Inv Relation |
• – – |
2016-01-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
950 |
53,012 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
